Skip to main content

Medical materials

Symposium
  • APLAR
  • 5 September, 2025

Management of MAS and Still’s Disease: Challenges and opportunities

Masaki Shimizu, Fabrizio De Benedetti

Available materials

Publication
  • APLAR
  • 3 September, 2025

Efficacy and Safety of Emapalumab for Treating Macrophage Activation Syndrome in Still’s disease: A Pooled Analysis of Two Prospective Trials

Masaki Shimizu, Alexei A. Grom, Uwe Ullmann, Adnan Mahmood, Josefin Blomkvist, Brian D. Jamieson, Fabrizio De Benedetti

Available materials

Sign up for alerts